|Videos|May 27, 2023
Discussing Rapid Accurate mRNA Potency Assay Possibilities with Sean Hart
Author(s)Chris Spivey
Sean Hart, CEO and SCO of LumaCyte, discusses rapid accurate mRNA potency assay possibilities.
Advertisement
Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on the topic of rapid accurate mRNA potency assay possibilities.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech’s Top 10 Articles of 2025
2
The Year of AI: 2025’s Bio/pharma Upskilling Revolution
3
Strategies for Building Pharmaceutical Supply Chain Resilience in a Shifting Market
4
Missteps in GMP Facilities and Equipment Maintenance
5